Skip to main content

Von Willebrand Diseases clinical trials at UC Health
2 in progress, 1 open to eligible people

  • Clinical Performance Evaluation of T-TAS 01 PL Chip

    open to eligible people ages 21 years and up

    This study will measure primary hemostatic ability using the T-TAS 01 System with PL chip, with a comparison to clinical truth.

    at UCSF

  • ATHN 9: Severe VWD Natural History Study

    Sorry, accepting new patients by invitation only

    ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) in adult and pediatric participants with clinically severe congenital VWD.

    at UCSD

Last updated: